Hepatitis C is generally considered the most serious because it often becomes chronic and can silently damage your liver for decades
Hepatitis C stands out as the most dangerous of the three common viral hepatitis types (A, B, and C) for one main reason: most people who catch it never clear the virus on their own. About 70 to 85 percent of infected people develop chronic hepatitis C, meaning the virus stays in their body for life. During those years—sometimes 20 or 30 years—the virus slowly scars liver tissue. By the time someone notices symptoms, cirrhosis (severe scarring) or liver cancer may already be present.
Hepatitis A and B are serious acute illnesses that make you feel very sick quickly, but most adults recover completely. Hepatitis C is different: it is quiet. You can feel fine while your liver is being damaged, which is why many people discover they have it only during a blood test for an unrelated reason, or when liver problems finally appear.
Key Takeaways
- Hepatitis C becomes chronic in most people and can cause cirrhosis or liver cancer without any symptoms for decades.
- Hepatitis A causes acute illness but almost always resolves completely; chronic hepatitis A does not exist.
- Hepatitis B can become chronic and cause serious liver damage, but modern vaccines prevent infection in most vaccinated people.
- New medications can cure hepatitis C in 8 to 12 weeks, which has changed the outlook for people diagnosed today.
- The danger of each type depends on whether you develop chronic infection and how quickly you receive treatment.
How Hepatitis A, B, and C differ in what they do to your liver
The three viruses cause different patterns of illness. Hepatitis A infects your liver, causes inflammation, and makes you acutely ill—fever, fatigue, jaundice (yellowing of skin and eyes), abdominal pain. But your immune system clears the virus within weeks to months. Once you recover, you are immune for life and cannot get hepatitis A again. Chronic hepatitis A does not happen.
Hepatitis B also causes acute illness in some people, but many—especially infants and young children—have no symptoms at all when first infected. About 5 to 10 percent of infected adults develop chronic hepatitis B, meaning the virus persists in their blood. Over years or decades, chronic hepatitis B can cause cirrhosis and liver cancer. However, a vaccine prevents hepatitis B infection in most people who receive it.
Hepatitis C often causes no symptoms during acute infection, so many people do not know they are infected. The virus then becomes chronic in 70 to 85 percent of cases. Chronic hepatitis C slowly damages liver cells through inflammation and scarring. Without treatment, it can progress to cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer).
Why hepatitis C's silent progression makes it especially dangerous
The real threat from hepatitis C is that it hides. Someone can carry the virus for 10, 20, or 30 years and feel completely well. During that time, the liver is being scarred. By the time symptoms appear—fatigue, abdominal swelling, confusion, or bleeding—the damage may be irreversible.
This silent progression is why hepatitis C screening is now recommended for all adults at least once in their lifetime, according to the Centers for Disease Control and Prevention. A simple blood test can detect the virus. If you have it, another blood test can show whether your liver is already scarred. Knowing your status early matters because treatment works best before cirrhosis develops.
Treatment options have changed the picture for hepatitis C
Until the early 2010s, hepatitis C treatment was difficult, had severe side effects, and did not work for everyone. That changed with the arrival of direct-acting antivirals—medications that target the hepatitis C virus directly. These drugs can cure hepatitis C in 8 to 12 weeks with cure rates above 95 percent and minimal side effects.
This means someone diagnosed with hepatitis C today has a very different outlook than someone diagnosed 15 years ago. Early diagnosis followed by treatment can prevent cirrhosis, liver cancer, and liver transplant. The challenge now is access: these medications are expensive, though many insurance plans and government programs cover them, and prices have been falling.
Hepatitis B can also become serious, but prevention is highly effective
While hepatitis C is more common as a chronic infection, hepatitis B can be equally serious once it becomes chronic. Chronic hepatitis B carries the same risks: cirrhosis, liver failure, and liver cancer. Some people with chronic hepatitis B need lifelong antiviral medication to slow liver damage.
The difference is prevention. The hepatitis B vaccine is highly effective and is given routinely to infants and children in the United States. Adults who were not vaccinated as children can receive the vaccine now. If you know you have been exposed to hepatitis B or have risk factors, vaccination or post-exposure prophylaxis (a preventive medication given shortly after exposure) can stop infection before it starts.
Cirrhosis and liver cancer: the end-stage risks all three can cause
All three hepatitis viruses can eventually lead to cirrhosis if chronic infection develops and goes untreated. Cirrhosis means so much of the liver is scarred that it cannot function. Symptoms include fluid buildup in the abdomen and legs, confusion, bleeding from the digestive tract, and kidney failure. Cirrhosis is not reversible, though treatment can slow its progression.
Hepatocellular carcinoma (liver cancer) is another shared risk, especially in people with cirrhosis. Hepatitis B and C are the leading causes of liver cancer worldwide. Hepatitis A does not cause cirrhosis or cancer because it does not become chronic.
Once cirrhosis develops, the only cure is a liver transplant. Transplant is life-saving but requires lifelong immunosuppressive medications and carries its own risks. This is why early detection and treatment—especially for hepatitis C—matter so much.
Who is at highest risk for each type
Risk varies by virus. Hepatitis A spreads through contaminated food or water, so risk is higher in areas with poor sanitation or during outbreaks. Hepatitis B spreads through blood and body fluids, so risk is higher for people who inject drugs, have unprotected sex with an infected partner, or were born in countries where hepatitis B is common. Hepatitis C also spreads through blood, so people who inject drugs or received a blood transfusion before 1992 (when screening improved) are at higher risk.
Knowing your risk helps you decide whether to get tested or vaccinated. If you have ever injected drugs, even once, the CDC recommends hepatitis C testing. If you were born between 1945 and 1965, you are in a birth cohort with higher hepatitis C rates and should be tested at least once.
Frequently Asked Questions
Can you have more than one type of hepatitis at the same time?
Yes. Someone can have hepatitis B and C together, or hepatitis A on top of chronic hepatitis B or C. Having multiple types usually means more severe illness and faster progression to cirrhosis. This is another reason testing for all three is important if you have risk factors.
If I had hepatitis A, can I get it again?
No. Once you recover from hepatitis A, your immune system remembers the virus and protects you for life. You cannot get hepatitis A twice. This is one reason hepatitis A is considered less serious than B or C—recovery means permanent immunity.
How long does it take for hepatitis C to cause cirrhosis?
It varies widely. Some people develop cirrhosis within 10 to 15 years; others take 30 years or more. Factors that speed progression include heavy alcohol use, hepatitis B co-infection, HIV co-infection, and older age at infection. Without treatment, most people with chronic hepatitis C will eventually develop cirrhosis if they live long enough.
Is hepatitis B vaccine effective if I am already an adult?
Yes, but effectiveness depends on age and immune status. Adults under 60 have a 95 percent response rate to the vaccine. Adults over 60 have a lower response rate, around 50 to 70 percent. A blood test after vaccination can confirm whether you developed immunity. If you did not, a higher-dose vaccine is available.
Can hepatitis C be cured?
Yes, with direct-acting antiviral medications. Treatment cures hepatitis C in more than 95 percent of people who take it as prescribed. However, cure means the virus is gone—it does not reverse cirrhosis if it has already developed. This is why early treatment, before cirrhosis forms, is so important.